F2RL1 and colorectal cancer: This mechanistic framework positions PAR-2 as a druggable node through which statins can redirect inflammatory survival signalling toward programmed cell demise, with potential implications for translating these laboratory findings to bedside clinical practice in colorectal cancer management.